Literature DB >> 10645897

Role of neuronal nitric oxide synthase in regulation of vascular and ductus arteriosus tone in the ovine fetus.

R L Rairigh1, L Storme, T A Parker, T D Le Cras, N Markham, M Jakkula, S H Abman.   

Abstract

Nitric oxide (NO) is produced by NO synthase (NOS) and contributes to the regulation of vascular tone in the perinatal lung. Although the neuronal or type I NOS (NOS I) isoform has been identified in the fetal lung, it is not known whether NO produced by the NOS I isoform plays a role in fetal pulmonary vasoregulation. To study the potential contribution of NOS I in the regulation of basal fetal pulmonary vascular resistance (PVR), we studied the hemodynamic effects of a selective NOS I antagonist, 7-nitroindazole (7-NINA), and a nonselective NOS antagonist, N-nitro-L-arginine (L-NNA), in chronically prepared fetal lambs (mean age 128 +/- 3 days, term 147 days). Brief intrapulmonary infusions of 7-NINA (1 mg) increased basal PVR by 37% (P < 0.05). The maximum increase in PVR occurred within 20 min after infusion, and PVR remained elevated for up to 60 min. Treatment with 7-NINA also increased the pressure gradient between the pulmonary artery and aorta, suggesting constriction of the ductus arteriosus (DA). To test whether 7-NINA treatment selectively inhibits the NOS I isoform, we studied the effects of 7-NINA and L-NNA on acetylcholine-induced pulmonary vasodilation. The vasodilator response to acetylcholine remained intact after treatment with 7-NINA but was completely inhibited after L-NNA, suggesting minimal effects on endothelial or type III NOS after 7-NINA infusion. Western blot analysis detected NOS I protein in the fetal lung and great vessels including the DA. NOS I protein was detected in intact and endothelium-denuded vessels, suggesting that NOS I is present in the medial or adventitial layer. We conclude that 7-NINA, a selective NOS I antagonist, increases basal PVR, systemic arterial pressure, and DA tone in the late-gestation fetus and that NOS I protein is present in the fetal lung and great vessels. We speculate that NOS I may contribute to NO production in the regulation of basal vascular tone in the pulmonary and systemic circulations and the DA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10645897     DOI: 10.1152/ajplung.2000.278.1.L105

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  10 in total

1.  Finding genetic contributions to sporadic disease: a recessive locus at 12q24 commonly contributes to patent ductus arteriosus.

Authors:  Arya Mani; Seyed-Mahmoud Meraji; Roozbeh Houshyar; Jayaram Radhakrishnan; Alaleh Mani; Mehrabeh Ahangar; Tayebeh M Rezaie; Mohammad-Ali Taghavinejad; Behrooz Broumand; Hongyu Zhao; Carol Nelson-Williams; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-30       Impact factor: 11.205

2.  Ovine bronchial-derived relaxing factor: changes with development and hyperoxic ventilation.

Authors:  Satyan Lakshminrusimha; Frederick C Morin; Robin H Steinhorn; Sylvia F Gugino; Rita M Ryan; Vasanth H Kumar; James A Russell
Journal:  J Appl Physiol (1985)       Date:  2006-03-30

3.  Threshold levels of extracellular l-arginine that trigger NOS-mediated ROS/RNS production in cardiac ventricular myocytes.

Authors:  Jayalakshmi Ramachandran; R Daniel Peluffo
Journal:  Am J Physiol Cell Physiol       Date:  2016-11-30       Impact factor: 4.249

4.  Selective type 5 phosphodiesterase inhibition alters pulmonary hemodynamics and lung liquid production in near-term fetal lambs.

Authors:  Robert C Dukarm; Robin H Steinhorn; James A Russell; Satyan Lakshminrusimha; Daniel Swartz; James J Cummings
Journal:  J Appl Physiol (1985)       Date:  2005-08-25

5.  Interactions between NO, CO and an endothelium-derived hyperpolarizing factor (EDHF) in maintaining patency of the ductus arteriosus in the mouse.

Authors:  B Baragatti; F Brizzi; S Barogi; V E Laubach; D Sodini; E G Shesely; R F Regan; F Coceani
Journal:  Br J Pharmacol       Date:  2007-03-12       Impact factor: 8.739

6.  Erythropoietin and hypoxia increase erythropoietin receptor and nitric oxide levels in lung microvascular endothelial cells.

Authors:  Bojana B Beleslin-Čokić; Vladan P Cokić; Li Wang; Barbora Piknova; Ruifeng Teng; Alan N Schechter; Constance T Noguchi
Journal:  Cytokine       Date:  2011-02-15       Impact factor: 3.861

7.  Hypoxia-induced caspase-3 activation and DNA fragmentation in cortical neurons of newborn piglets: role of nitric oxide.

Authors:  N A Parikh; C D Katsetos; Q M Ashraf; S H Haider; A Legido; M Delivoria-Papadopoulos; O P Mishra
Journal:  Neurochem Res       Date:  2003-09       Impact factor: 3.996

8.  Nitric oxide signalling pathway in Duchenne muscular dystrophy mice: up-regulation of L-arginine transporters.

Authors:  Jayalakshmi Ramachandran; Joel S Schneider; Pierre-Antoine Crassous; Ruifang Zheng; James P Gonzalez; Lai-Hua Xie; Annie Beuve; Diego Fraidenraich; R Daniel Peluffo
Journal:  Biochem J       Date:  2013-01-01       Impact factor: 3.857

9.  Cyclooxygenase-1 and cyclooxygenase-2 in the mouse ductus arteriosus: individual activity and functional coupling with nitric oxide synthase.

Authors:  B Baragatti; F Brizzi; C Ackerley; S Barogi; L R Ballou; F Coceani
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

10.  Use of off-label compounded oral sildenafil in the management of persistent pulmonary hypertension of the newborn: A case report.

Authors:  Olapeju Daniyan; Obumneme Ezeanosike; Dorathy Obu; Fortune Ujunwa
Journal:  J Cardiovasc Thorac Res       Date:  2022-03-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.